Analgesics

Analgesics in Austria continued to see strong growth in retail current value sales terms in 2022, with positive, if more moderate, increments in retail volume terms. Growth was driven by sales of systemic and topical analgesics alike. Many consumers…

While in 2022 Pakistan largely put the disruptions caused by COVID-19 behind it, there were other challenges. Spiralling inflation, massive devaluation of the Pakistani rupee against major world currencies and catastrophic floods, which left hundreds…

Analgesics has been experiencing an upturn in demand in 2022, driven by rising cases of influenza. In addition, the increasing use of analgesics in Germany is also a result of the Omicron variant taking its toll during the year. The emergence of…

Cameroon has not been as affected by the energy crisis stemming from the war in Ukraine as many other countries. Rising global energy prices in 2022 are giving a boost to government coffers and helping stabilise the economy. However, ongoing civil…

Analgesics has seen stronger growth in current value terms in 2022, with sales benefiting from the easing of COVID-19 restrictions. Following the lifting of these restrictions there was a spike in cases of COVID-19. With the symptoms being relatively…

In 2021, demand for analgesics increased, as consumers used these products as an effective countermeasure against the side-effects of COVID-19 vaccination, such as high fever and headache, or stocked these products in preparation for home treatment…

Having performed particularly strongly during 2021, as the rate of COVID-19 infections in the country spiked, retail constant value sales (2022 prices) of analgesics exhibited a marginal decline in 2022. A sharp fall in the incidence of the virus was…

At the start of the COVID-19 pandemic systemic analgesics, such as acetaminophen and aspirin witnessed a surge in usage as they were recommended by the Bolivian government as effective treatments to support Coronavirus sufferers and also as a…

Polish consumers have been using analgesics widely for years. According to a 2020 survey conducted by the Central Statistical Office, almost half of the adult population admit to using them. The COVID-19 pandemic exacerbated this trend, as these…

Sales of analgesics are set to enjoy appreciable progression in 2022, following an already surprisingly robust performance at the end of 2021. Most players anticipated a strong comeback from typical pre-pandemic ailments in 2022. Nonetheless, it came…

In early 2022, India witnessed a less intense third wave of COVID-19, while the country’s successful vaccination eased local consumers’ fears. Accordingly, the government further eased restrictions placed on gyms, health centres, and sports clubs,…

Amid rising inflation in 2022, consumers face lower levels of disposable income with price becoming a more pivotal factor when purchasing analgesics. Some consumers favour retail outlets where they can be assured of low prices, even though choice is…

Analgesics is witnessing a growth surge in 2022 as pandemic-related restrictions are lifted and social/professional life shifts back to a more normal mode. A high proportion of analgesics are used to tackle seasonal colds and flu symptoms, which is…

Analgesics remains amongst the largest and most dynamic categories in the OTC market in Egypt. The strong performance of the category is being supported by organic population growth and the fact that, unlike digestive remedies and cough, cold and…

Analgesics has witnessed a strong recovery in current value terms in 2022 as consumers have come out of lockdown and there has been increased social activity and therefore also more cases of cold and flu. The growth of the category continues to be…

The pandemic encouraged many local consumers to limit the number of visits to the doctor in 2020/2021, especially those suffering from minor symptoms. As such, this led to a decline for Rx prescription analgesics, a factor which boosted OTC sales…

Analgesics was positively impacted by the emergence of the COVID-19 pandemic, with a surge in demand for the most popular type, acetaminophen, due to stockpiling or panic-buying. Acetaminophen is considered a universal painkiller by many consumers…

Local players such as Vitaflenaco and generics have seen strong gains in the past two years as consumers have been more price sensitive since the COVID-19 pandemic and sought more affordable options. Current value sales of analgesics are rising…

Systemic analgesics has experienced a fluctuating performance since the emergence of the pandemic in China. In 2020, sales of systemic analgesics slumped by double digits due to the stringent measures that were taken to monitor retail sales of…

As part of a general healthier lifestyle trend, there is a growing propensity of Turkish consumers to engage in outdoor activities, sports, and exercise, and this is boosting demand for analgesics due to the higher risk of injuries. Although the…